SCHEMBL3479783

SCHEMBL3479783

CN1CCN(c2ccc(F)c(F)c2)c2ccc(N3CCNCC3)cc2C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 6/20 0.40
HTT P42858 2/20 0.38
KDM4E B2RXH2 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
RECQL P46063 1/20 0.38
PTK2B Q14289 1/20 0.38
MAPKAPK2 P49137 2/20 0.37
HTR6 P50406 3/20 0.37
DRD3 P35462 1/20 0.37
HTR3E A5X5Y0 3/20 0.36
HTR3B O95264 3/20 0.36
HTR3A P46098 3/20 0.36
HTR3D Q70Z44 3/20 0.36
HTR3C Q8WXA8 3/20 0.36
SIGMAR1 Q99720 3/20 0.36
TGFBR1 P36897 1/20 0.36
ACVR1 Q04771 1/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3479739 0.91 GAA (0.46) HTTKDM4EGAAMAPTMAPK1
SCHEMBL3479410 0.88 HTR1A (0.45) ADRB1HTTKDM4EGAAMAPT
SCHEMBL3479564 0.87 ADRB1 (0.40) ADRB1HTTKDM4EGAAMAPT
SCHEMBL3228169 0.86 LGMN (0.41) HTTKDM4EGAAMAPTMAPK1
SCHEMBL3479556 0.85 ADRB1 (0.51) ADRB1HTTMAPKAPK2HTR6HTR3E
SCHEMBL3479608 0.85 ALDH1A1 (0.42) ADRB1HTTKDM4EGAAMAPT
SCHEMBL3479645 0.85 HTR3A (0.41) ADRB1HTTKDM4EGAAMAPT
SCHEMBL3239201 0.84 ADRB1 (0.47) ADRB1HTTHTR6DRD3HTR3E
SCHEMBL3479712 0.83 ADRB1 (0.59) ADRB1HTTKDM4EGAAMAPT
SCHEMBL3479611 0.82 ALDH1A1 (0.46) HTTKDM4EGAAMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D ADRB1 2/4885HTT 1634/4885KDM4E 921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.